These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16936418)

  • 1. Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revascularization Trial (SMART).
    Ota S; Nishikawa H; Takeuchi M; Nakajima K; Nakamura T; Okamoto S; Setsuda M; Makino K; Yamakado T; Nakano T
    Circ J; 2006 Sep; 70(9):1099-104. PubMed ID: 16936418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.
    Lim SY; Bae EH; Jeong MH; Kang DG; Lee YS; Kim KH; Lee SH; Yoon KH; Hong SN; Park HW; Hong YJ; Kim JH; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
    Circ J; 2004 Oct; 68(10):928-32. PubMed ID: 15459466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction.
    Lee HC; An SG; Choi JH; Lee TK; Kim J; Kim JH; Chun KJ; Hong TJ; Shin YW; Lee SK
    Circ J; 2008 Sep; 72(9):1425-9. PubMed ID: 18724016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction.
    Ito H; Taniyama Y; Iwakura K; Nishikawa N; Masuyama T; Kuzuya T; Hori M; Higashino Y; Fujii K; Minamino T
    J Am Coll Cardiol; 1999 Mar; 33(3):654-60. PubMed ID: 10080465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial.
    Zhang W; Dai J; Zheng X; Xu K; Yang X; Shen L; Wang X; Hao Z; Qiu X; Jiang L; Shi H; Shen L; He B
    Medicine (Baltimore); 2021 Apr; 100(15):e25551. PubMed ID: 33847683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
    Feng C; Liu Y; Wang L; Niu D; Han B
    Heart Lung Circ; 2019 Jun; 28(6):858-865. PubMed ID: 29891250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Grygier M; Araszkiewicz A; Lesiak M; Janus M; Kowal J; Skorupski W; Pyda M; Mitkowski P; Grajek S
    Am J Cardiol; 2011 Apr; 107(8):1131-5. PubMed ID: 21310372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Suppressive effect of nicorandil in ventricular arrhythmias after reperfusion therapy in patients with acute myocardial infarction].
    Hara H; Horinaka S; Yabe A; Yagi H; Tsuboko Y; Yoshida K; Iemura T; Matsuoka H
    J Cardiol; 2007 Mar; 49(3):135-41. PubMed ID: 17444139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous nicorandil before reperfusion for acute myocardial infarction in patients with stress hyperglycemia.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Matsubara T; Murohara T
    Diabetes Care; 2006 Feb; 29(2):202-6. PubMed ID: 16443860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.
    Peng Y; Fu X; Li W; Geng W; Xing K; Ru L; Sun J; Zhao Y
    Coron Artery Dis; 2014 Dec; 25(8):645-52. PubMed ID: 25230304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction.
    Kobatake R; Sato T; Fujiwara Y; Sunami H; Yoshioka R; Ikeda T; Saito H; Ujihira T
    Heart Vessels; 2011 Jul; 26(4):379-84. PubMed ID: 21110199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.
    Ono H; Osanai T; Ishizaka H; Hanada H; Kamada T; Onodera H; Fujita N; Sasaki S; Matsunaga T; Okumura K
    Am Heart J; 2004 Oct; 148(4):E15. PubMed ID: 15459610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of corrected thrombolysis in myocardial infarction frame count and ST-segment resolution to myocardial tissue perfusion after acute myocardial infarction.
    Li CM; Zhang XH; Ma XJ; Zhu XL
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):312-7. PubMed ID: 18288744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Ji Z; Zhang R; Lu W; Ma G; Qu Y
    Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
    J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
    Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
    Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.